Join us for an in-depth webinar designed to equip independent pharmacy owners and potential buyers with the knowledge needed to thrive in today’s market. We’ll delve into critical topics, including:
- FDA scrutiny of compounded GLP-1s and other peptide products;
- The evolving distinction between permissible compounding and products that may be viewed as “essentially copies” of commercially available drugs;
- 503A and 503B considerations;
- Board of Pharmacy enforcement risks;
- Documentation and prescriber/patient-specific considerations;
- Advertising and marketing pitfalls; and
- Practical steps pharmacies can take to reduce regulatory and litigation risk.
This webinar provides actionable insights to help you make informed decisions about your pharmacy’s future. Don’t miss this opportunity to gain a competitive edge in the dynamic pharmacy market.
